# Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancer

> **NCT00482807** · PHASE1 · COMPLETED · sponsor: **University of Nebraska** · enrollment: 9 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** bicalutamide
- **DRUG:** docetaxel
- **DRUG:** goserelin
- **RADIATION:** intensity-modulated radiation therapy

## Key facts

- **NCT ID:** NCT00482807
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08-31
- **Primary completion:** 2010-03-09
- **Final completion:** 2010-03-09
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2023-11-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00482807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00482807, "Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00482807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*